Cargando…

P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS

Detalles Bibliográficos
Autores principales: Garciaz, Sylvain, Bories, Pierre, Lopez Almeida, Leonor, Boher, Jean-Marie, Belanger, Coralie, Recher, Christian, Hermine, Olivier, Vey, Norbert, Launay, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429269/
http://dx.doi.org/10.1097/01.HS9.0000969100.45170.e9
_version_ 1785090669289668608
author Garciaz, Sylvain
Bories, Pierre
Lopez Almeida, Leonor
Boher, Jean-Marie
Belanger, Coralie
Recher, Christian
Hermine, Olivier
Vey, Norbert
Launay, Pierre
author_facet Garciaz, Sylvain
Bories, Pierre
Lopez Almeida, Leonor
Boher, Jean-Marie
Belanger, Coralie
Recher, Christian
Hermine, Olivier
Vey, Norbert
Launay, Pierre
author_sort Garciaz, Sylvain
collection PubMed
description
format Online
Article
Text
id pubmed-10429269
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104292692023-08-17 P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS Garciaz, Sylvain Bories, Pierre Lopez Almeida, Leonor Boher, Jean-Marie Belanger, Coralie Recher, Christian Hermine, Olivier Vey, Norbert Launay, Pierre Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429269/ http://dx.doi.org/10.1097/01.HS9.0000969100.45170.e9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Garciaz, Sylvain
Bories, Pierre
Lopez Almeida, Leonor
Boher, Jean-Marie
Belanger, Coralie
Recher, Christian
Hermine, Olivier
Vey, Norbert
Launay, Pierre
P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
title P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
title_full P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
title_fullStr P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
title_full_unstemmed P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
title_short P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
title_sort p548: preliminary results of a phase 1, first-in-human study of ina03, an anti-cd71 antibody-drug conjugate in patients with relapsed or refractory (r/r) acute leukemias
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429269/
http://dx.doi.org/10.1097/01.HS9.0000969100.45170.e9
work_keys_str_mv AT garciazsylvain p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias
AT boriespierre p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias
AT lopezalmeidaleonor p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias
AT boherjeanmarie p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias
AT belangercoralie p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias
AT recherchristian p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias
AT hermineolivier p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias
AT veynorbert p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias
AT launaypierre p548preliminaryresultsofaphase1firstinhumanstudyofina03ananticd71antibodydrugconjugateinpatientswithrelapsedorrefractoryrracuteleukemias